After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Intellia Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Intellia Therapeutics Inc is $1.32B. A total of 7.71 million shares were traded on the day, compared to an average of 7.16M shares.
In the most recent transaction, Schultes Birgit C sold 31 shares of NTLA for 17.38 per share on Oct 01 ’25. After the transaction, the EVP, Chief Scientific Officer now owns 105,184 company shares. In a previous transaction on Oct 01 ’25, Dube Michael P sold 1,871 shares at 17.38 per share. NTLA shares that VP, Chief Accounting Officer owns now total 55,266.
Among the insiders who bought shares, CHASE WILLIAM J acquired of 100,000 shares on Aug 20 ’25 at a per-share price of $10.03. This resulted in the Director holding 134,693 shares of NTLA after the transaction. In another insider transaction, Dulac Edward J III sold 7,462 shares at $14.02 per share on Jul 23 ’25. Company shares held by the EVP, Chief Financial Officer now total 106,062.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NTLA has a high of $28.25 and a low of $5.90.
As of this writing, NTLA has an earnings estimate of -$0.94 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $0.04 per share and a lower estimate of -$1.2. The company reported an EPS of -$1.27 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NTLA’s latest balance sheet shows that the firm has $748.69M in Cash & Short Term Investments as of fiscal 2021. There were $74.02M in debt and $125.83M in liabilities at the time. Its Book Value Per Share was $6.79, while its Total Shareholder’s Equity was $1.04B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTLA is Buy with a score of 4.00.
